Activation of human T cells by a tumor vaccine infected with recombinant Newcastle disease virus producing IL-2
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2008-10-01 / Int. J. Oncol. 2008 Oct;33(4):823-32Effect of combined therapy with the antiestrogen agent toremifene and local hyperthermia on breast cancer cells implanted in nude mice
/in Breast Cancer, Hyperthermia, International Publications /von 2008-09-27 / Surg. Today 2008;38(10):911-20Vaccination with autologous tumor-loaded dendritic cells induces clinical and immunologic responses in indolent B-cell lymphoma patients with relapsed and measurable disease: a pilot study
/in International Publications, Malignant Lymphoma /von 2008-09-22 / Blood 2009 Jan;113(1):18-27The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience
/in Acute Leukemia, Dendritic Cells, International Publications /von 2008-09-20 / Pathol. Oncol. Res. 2009 Jun;15(2):257-67Cancer immunotherapy by dendritic cells
/in Dendritic Cells, International Publications /von 2008-09-19 / Immunity 2008 Sep;29(3):372-83Immunohistological analysis of peptide-induced delayed-type hypersensitivity in advanced melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination
/in International Publications, Malignant Melanoma /von 2008-09-19 / J. Dermatol. Sci. 2009 Jan;53(1):40-7In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells
/in Hepatocellular Carcinoma, International Publications /von 2008-09-15 / J Transl Med 2008 Sep;6:51Dendritic cell vaccines in acute leukaemia
/in Acute Leukemia, International Publications /von 2008-09-01 / Best Pract Res Clin Haematol 2008 Sep;21(3):521-41Vaccine therapy and chronic lymphocytic leukaemia
/in Chronic Leukemia, International Publications /von 2008-09-01 / Best Pract Res Clin Haematol 2008 Sep;21(3):421-36IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de